Please login to the form below

Not currently logged in
Email:
Password:

Menarini

This page shows the latest Menarini news and features for those working in and with pharma, biotech and healthcare.

New cancer meds and drug extensions top CHMP recommendations

New cancer meds and drug extensions top CHMP recommendations

This includes Adenuric, blockbuster oncology treatment Avastin (bevacizumab) from Roche; AbbVie's auto-inflammatory drug Humira (adalimumab), Menarini's gout drug Adenuric, (febuxostat), the rare disease drug for kidney disease Soliris

Latest news

More from news
Approximately 4 fully matching, plus 22 partially matching documents found.

Latest Intelligence

  • Pharma deals in April 2015 Pharma deals in April 2015

    Dr Reddy's, Menarini and Cipher Pharmaceuticals have acquired or licensed rights to products in South Asia, Asia Pacific (ex-Japan) and North America and Mexico, respectively.  . ... Menarini AP will be responsible for the clinical development,

  • Medius Deal Watch table for April 2015 Medius Deal Watch table for April 2015

    120. 4SC AG/Menarini. Licensing and development agreement. Resminostat (oral HDAC) for hepatocellular carcinoma.

  • Deal Watch table for July 2013 Deal Watch table for July 2013

    130‡. Vivus / Berlin-Chemie  (Menarini). Licence, commercialisation, supply. Spedra (avanafil) for erectile dysfunction (approved).

  • Pharma investment in Indonesia Pharma investment in Indonesia

    Two years prior to its acquisition by the Italian Menarini group in Dec 2012, the Invida Group acquired 70 per cent stake of Indonesian pharmaceutical manufacturer MUGI.

  • Pharma deals during October 2012 Pharma deals during October 2012

    indications. Whilst Oxford BioTherapeutics will be responsible for the discovery activities, Menarini will lead on the manufacture and clinical development of each programme. ... Asia and Latin America. Whilst no financial terms have been disclosed, a

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Synergy Vision

    Amgen. Daiichi Sankyo. GlaxoSmithKline. Janssen Cilag. LEO Pharma. The Menarini Group.

  • Life wins at the Rx Club Show

    Menarini. Life also picked up 6 awards of excellence in the print category for Life self-promotion and for clients Galderma and Abbott. .

  • HAVAS LYNX

    Lundbeck. Martindale. Menarini. Merck Serono. Novartis. Novo Nordisk. Roche. Siemens. Teva.

  • SEVEN STONES

    Bayer. BD. Celgene. Dr Falk. Exercise Works. GE. Jazz. Menarini. MSD.

More from PMHub
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GK Strategy

GK is award-winning independent communications agency specialising in delivering impactful strategies for clients across the healthcare market....

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics